Deqsiga

human normal immunoglobulin · Takeda Manufacturing Austria AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Deqsiga, covering 2025-05-16 to 2025-05-16. Get the full timeline:

Most recent: EMA Authorised: Deqsiga (human normal immunoglobulin) — Takeda Manufacturing Austria AG